Friday, December 08, 2006

Peter Rost -- WOW.

›
In the wake of Pfizer's recent torcetrapib troubles, Dr. Peter Rost is really sticking it to Pfizer. His last paragraph is reproduced b...

Iloperidone Saves The Day

›
To see a very optimistic view of Vanda's iloperidone, read an article at the Red Herring . Here's a snippet: "Thomas Weisel an...

Congrats to Kazdin

›
A few days ago, Alan Kazdin won the election for American Psychological Association president. I couldn't be more pleased. Here are som...

Good Reader Comment

›
Earlier this week, in response to a post about diabetes medications potentially helping in weight management for children taking atypical a...

A Good Week for Atypical Antipsychotics?

›
According to a story in the Houston Chronicle , this is the case. First, we had Lilly assuaging investor fears that Zyprexa sales would d...
Thursday, December 07, 2006

Go Blackwell

›
Blackwell Publishing has issued a set of guidelines for its journal editors in order to increase transparency and smoke out conflicts of in...

More on Lexapro Vs. Cymbalta

›
Another press release on this study (see yesterday’s post for more details) indicated that the difference between medications on the MADRS ...

Cymbalta and Zyprexa: Good News

›
Upbeat Comments from Lilly’s president Dr. John Lechleiter about Zyprexa and Cymbalta: “Regarding Zyprexa, Lechleiter stated, "200...
Wednesday, December 06, 2006

A Silver Bullet?

›
A trial in the new American Journal of Psychiatry found that adding metformin to a regimen of atypical antipsychotic medications stopped ch...
1 comment:

Lexapro Beats Cymbalta

›
But was the full story really told? In a study released today by Forest Labs, its product Lexapro bested Lilly's Cymbalta in a head to ...
Tuesday, December 05, 2006

This is Depressing

›
A study by Kellner et al. in the December Archives of General Psychiatry examined long-term (okay, only six months, but that’s what goes f...

More Conflicts of Interest

›
I'll defer to the good folks at Health Care Renewal on this one. Teaser follows... "We have posted a lot about the story of wide-...

Advocating for Patients and/or Drugs

›
PharmaGossip has an interesting story this morning. Teaser below… “ Britain 's chief drug regulator has accused Big Pharma of cove...
2 comments:
Monday, December 04, 2006

Effects the Size of BOLDERs

›
Spelling error in title intentional. I got my hands on the BOLDER II study , which found that quetiapine (Seroquel) was an effective treatm...
3 comments:
Sunday, December 03, 2006

Meet The Last Psychiatrist

›
Great post over at The Last Psychiatrist regarding the biological bias that is predominant in psychiatry: biology counts, while other factor...
Saturday, December 02, 2006

Try This on For Sleazy

›
Wow... "Omnicare Inc., the largest provider of pharmacy services to U.S. nursing homes, agreed to pay $49.5 million to settle claims by...

Seroquel is Great...

›
And nobody paid me to say it [so it appears, misleadingly]... Liz Spikol noted recently that Dr. Lakshmi Yatham was pimping Seroquel for bip...

Drug Safety Monitoring Anyone?

›
A recent editorial in the New England Journal of Medicine discusses various instances of drug manufacturers hiding evidence that reflects po...

GSK: Commence "Phiring"

›
According to one source, GlaxoSmithKline will soon be following Pfizer's lead and significantly lopping off a chunk of its sales force. ...

Well DUH

›
"Eighty-six percent of the recent decline in U.S. teen pregnancy rates is the result of improved contraceptive use, while a small propo...